We’re at the time of year where we can cheerfully draw on numerous lessons learned from preclinical research and start applying them to the clinic.

Today’s adventure in the time and space continuum takes us on a brief journey from one solid tumour to potentially several others.

This is an emerging new niche with both small and large players already actively conducting R&D with implications for some interesting future combinations…

To learn more from our latest oncology expert interview and get a heads up on key cancer research insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by